Company Overview
American HealthCare Capital is pleased to exclusively introduce a well-established and highly profitable specialty medical device manufacturer located in Canada. The Company designs, manufactures, and distributes proprietary non-invasive therapeutic equipment used by healthcare providers to treat a range of musculoskeletal and pain-related conditions.
The Company has a longstanding operating history and an established international customer base. It maintains regulatory approvals and certifications supporting sales throughout North America and several major international markets. Its products are sold through a combination of direct sales representatives and an established network of independent international distributors.
Financial Overview
For the 11 months ended July 31, 2026, the Company generated approximately $2.96 million CAD in consolidated revenue and $1.51 million CAD in net income. This represents an annualized revenue run rate of approximately $3.23 million CAD and annualized net income of approximately $1.65 million CAD.
The Company has historically generated strong profitability and operates with no outstanding interest-bearing debt. Customers generally provide deposits before manufacturing begins, reducing the Company’s working capital requirements and limiting receivables exposure.
Operations and Growth Opportunities
The Company operates from an established manufacturing and administrative facility with sufficient capacity to support additional production. Its products are assembled using a combination of standardized components and custom-fabricated parts supported by complete engineering drawings and multiple supply relationships.
Growth opportunities include expanding direct sales coverage in the United States, strengthening established international distributor relationships, pursuing delayed international orders, and introducing recurring revenue through software updates, extended warranties, remote diagnostics, replacement accessories, and maintenance programs.
Management and Exit Plan
The Company maintains an experienced operational team responsible for regulatory compliance, manufacturing, purchasing, administration, sales, customer training, and technical support. A General Manager has assumed a significant portion of the owner’s historical responsibilities and is expected to provide operational continuity following a transaction.
The sole owner is pursuing a sale as part of a planned retirement and is willing to remain involved for an extended transition period to assist with distributor relationships, regulatory matters, and manufacturing handover.
Transaction Structure
The owner is seeking a sale of 100% of the Company’s equity and will consider all competitive offers. The manufacturing facility is held separately and may be leased to the buyer under a long-term agreement or potentially acquired through a separate transaction.